Warning! Your browser is extremely outdated and not web standards compliant.
Your browsing experience would greatly improve by upgrading to a modern browser.

Choose a Kemin website


Gut Health Solution Available to Swine Producers in Europe

Gut Health Solution Available to Swine Producers in Europe

Authorization of CLOSTAT® for sows published in Official Journal of EU

HERENTALS, Belgium (December 21, 2017) – Kemin, a global nutritional ingredient company that uses science to touch 3.8 billion people every day with its products and services, has received authorization from the European Commission for use of Bacillus subtilis PB6 (CLOSTAT®) in sows, effective Friday, December 29.

“Since its first registration, CLOSTAT has been widely used to manage gut health in poultry,” said Susanne Kirwan, Gut Health Product Manager for Kemin Animal Nutrition and Health, Europe. “The expanded registration provides a viable alternative for swine producers looking to reduce antibiotics while maintaining piglet health from birth to weaning.”

The patented strain of Bacillus subtilis can be used in sows starting at three weeks before farrowing throughout the whole lactation period. Piglets may also derive a benefit from the sow receiving the feed additive. The official authorization has been published in the Official Journal of the European Union.

To learn more about CLOSTAT, visit www.kemin.com/en/europe/products/clostat.


About Kemin Industries

Kemin (www.kemin.com) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.8 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need.

Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries.

A privately held, family owned and operated company, Kemin has more than 2,500 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States.

Media Contact:
Susanne Kirwan, Gut Health Product Manager, susanne.kirwan@kemin.com, +32 14 28 62 00

Upcoming Kemin Events


Jakarta, Indonesia

Jul 04